Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$64.39 – $207.71
12% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.36B | $1.43B | $1.32B | $1.50B | $1.65B | $1.94B | $2.24B | $2.34B |
| Cost of revenue | $361.2M | $351.1M | $344.4M | $410.2M | $411.0M | $488.0M | $562.1M | $615.2M |
| Gross profit | $1.00B | $1.08B | $976.2M | $1.09B | $1.24B | $1.45B | $1.67B | $1.73B |
| Gross margin | 73.5% | 75.4% | 73.9% | 72.6% | 75.1% | 74.8% | 74.9% | 73.7% |
| R&D | $167.7M | $184.4M | $185.1M | $195.0M | $210.7M | $244.9M | $277.0M | $291.5M |
| Operating income | $306.2M | $370.8M | −$243.9M | $370.2M | $402.4M | $389.5M | $475.0M | $406.1M |
| EBITDA | $383.2M | $409.3M | −$183.1M | $457.2M | $475.4M | $486.9M | $578.9M | $619.9M |
| Net income | $245.8M | $276.7M | −$238.3M | $326.5M | $289.1M | $300.6M | $356.8M | $388.9M |
| Net margin | 18.0% | 19.4% | -18.0% | 21.8% | 17.5% | 15.5% | 16.0% | 16.6% |
| EPS (diluted) | 4.27 | 4.79 | -4.00 | 4.93 | 4.40 | 4.56 | 5.43 | 5.93 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.3B | $4.74 | $4.51–$5.14 | 1 |
| 2027 | $2.4B | $5.30 | $5.05–$5.75 | 1 |
| 2028 | $2.6B | $5.84 | $5.57–$6.34 | 1 |
| 2029 | $2.8B | $6.74 | $6.42–$7.32 | 1 |
Forward consensus · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CHEOFCochlear Limited | $81.42 | -1.08% | $5.3B | — |
| ALBBYAlibaba Health Information Technology Limited | $8.46 | +6.82% | $6.8B | — |
| BDUUYBangkok Dusit Medical Services Public Company Limited | $23.41 | +0.00% | $9.3B | — |
| ERFSFEurofins Scientific SE | $76.93 | +0.58% | $13.3B | — |
| FSPKFFisher & Paykel Healthcare Corporation Limited |
COCHLEAR PLC ORD
No one on the platform currently holds CHEOF.
No tracked institution reports a position in CHEOF as of their last filing.
No one on the platform has traded CHEOF yet.
| $22.52 |
| +0.00% |
| $13.2B |
| — |
| ORINFOrion Oyj | $82.75 | +0.00% | $11.7B | — |
| SONVFSonova Holding AG | $235.45 | +2.81% | $14.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 8.8× earnings vs its 34.6× historical median P/E.
Fair value ≈ $321.05 · price $81.42 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.